Anyplex™Ⅱ HPV28 Detection simultaneously detects, differentiates and quantifies 28 distinct HPV genotypes (19 high-risk and 9 low-risk) responsible for cervical cancer and/or sexually transmitted infections. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this multiplex assay performs on real-time PCR instrument and provides high sensitivity and specificity genotyping information of infected 28 HPV types in a single reaction
Detection and identification of 19 high-risk HPV and 9 low-risk HPV in a single reaction
Whole process validation from extraction to PCR by whole process control
Useful tool for surveillance and infection control
Convenient workflow using Seegene’s automated one platform
Quantitative analysis by cyclic-CMTA
Utilization of the UDG system to prevent carry-over contamination
Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
Automated data interpretation and LIS interlocking with Seegene Viewer
Assistant of appropriate treatment and management for co-infection
The result represents co-infection that HPV 16 is high (+++) in the HEX channel, HPV 52 is high(+++) in the Cal Red 610 channel, HPV 35, 61 are high (+++) in the Quasar 670 channel and HPV 40 is intermediate (++) in the Quasar 705 channel .
- Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions
- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities
- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.